So in 2014, the FDA began approving these medications for weight loss first Saxenda (liraglutide) , then Wegovy (semaglutide) , Zepbound (tirzepatide) , and most recently, Foundayo (orforglipron)
Researchers also investigate small molecule GLP-1R agonists non-peptide pills that can activate the GLP-1 receptor
They even had a small but statistically significant reduction in depressive symptoms
The researchers concluded that saffrons effects appear to work through mood improvementwhen people feel better emotionally, theyre less likely to snack due to stress, boredom, or anxiety
8.2 The Saturation Hypothesis From SURPASS-CVOT SURPASS-CVOT compared tirzepatide directly with dulaglutide and met its prespecified noninferiority margin but not formal superiority (HR 0.92, 95.3% CI 0.831.01
The data shows that even late responders achieved substantial weight loss by week 72